Literature DB >> 12674656

Large in-frame deletions of the rod-shaped domain of the dystrophin gene resulting in severe phenotype.

Yoram Nevo1, Francesco Muntoni, Caroline Sewry, Cyril Legum, Miriam Kutai, Shaul Harel, Victor Dubowitz.   

Abstract

BACKGROUND: The prediction that Duchenne muscular dystrophy patients have out-of-frame deletions and Becker muscular dystrophy patients have in-frame deletions of the dystrophin gene holds well in the vast majority of cases. Large in-frame deletions involving the rod domain only have usually been associated with mild (BMD) phenotype.
OBJECTIVES: To describe unusual cases with large in-frame deletions of the rod-shaped domain of the dystrophin gene associated with severe (Duchenne) clinical phenotype
METHODS: Screening for dystrophin gene deletion was performed on genomic DNA by using multiplex polymerase chain reaction. Needle muscle biopsies from the quadriceps were obtained using a Bergström needle. The biopsies were stained with histologic and histochemical techniques as well as monoclonal antibodies to dystrophin 1, 2 and 3.
RESULTS: In three children with large in-frame deletions of the rod domain (exons 10-44, 13-40 and 3-41), early-onset weakness and a disease course suggested the DMD phenotype.
CONCLUSIONS: This observation emphasizes the uncertainty in predicting the Becker phenotype in a young patient based on laboratory evaluation, and that the clinical picture should always be considered.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12674656

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


  7 in total

1.  Microdystrophin ameliorates muscular dystrophy in the canine model of duchenne muscular dystrophy.

Authors:  Jin-Hong Shin; Xiufang Pan; Chady H Hakim; Hsiao T Yang; Yongping Yue; Keqing Zhang; Ronald L Terjung; Dongsheng Duan
Journal:  Mol Ther       Date:  2013-01-15       Impact factor: 11.454

2.  Assessment of the structural and functional impact of in-frame mutations of the DMD gene, using the tools included in the eDystrophin online database.

Authors:  Aurélie Nicolas; Céline Lucchetti-Miganeh; Rabah Ben Yaou; Jean-Claude Kaplan; Jamel Chelly; France Leturcq; Frédérique Barloy-Hubler; Elisabeth Le Rumeur
Journal:  Orphanet J Rare Dis       Date:  2012-07-09       Impact factor: 4.123

Review 3.  Systemic AAV Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy.

Authors:  Dongsheng Duan
Journal:  Mol Ther       Date:  2018-07-17       Impact factor: 11.454

4.  Clinical features of patients with dystrophinopathy sharing the 45-55 exon deletion of DMD gene.

Authors:  Antonella Taglia; Roberta Petillo; Paola D'Ambrosio; Esther Picillo; Annalaura Torella; Chiara Orsini; Manuela Ergoli; Marianna Scutifero; Luigia Passamano; Alberto Palladino; Gerardo Nigro; Luisa Politano
Journal:  Acta Myol       Date:  2015-05

5.  Deletion of Dystrophin In-Frame Exon 5 Leads to a Severe Phenotype: Guidance for Exon Skipping Strategies.

Authors:  Zhi Yon Charles Toh; May Thandar Aung-Htut; Gavin Pinniger; Abbie M Adams; Sudarsan Krishnaswarmy; Brenda L Wong; Sue Fletcher; Steve D Wilton
Journal:  PLoS One       Date:  2016-01-08       Impact factor: 3.240

6.  A high-throughput digital script for multiplexed immunofluorescent analysis and quantification of sarcolemmal and sarcomeric proteins in muscular dystrophies.

Authors:  Dominic Scaglioni; Matthew Ellis; Francesco Catapano; Silvia Torelli; Darren Chambers; Lucy Feng; Caroline Sewry; Jennifer Morgan; Francesco Muntoni; Rahul Phadke
Journal:  Acta Neuropathol Commun       Date:  2020-04-17       Impact factor: 7.801

Review 7.  "Betwixt Mine Eye and Heart a League Is Took": The Progress of Induced Pluripotent Stem-Cell-Based Models of Dystrophin-Associated Cardiomyopathy.

Authors:  Davide Rovina; Elisa Castiglioni; Francesco Niro; Sara Mallia; Giulio Pompilio; Aoife Gowran
Journal:  Int J Mol Sci       Date:  2020-09-23       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.